Article
Using genetics to explore complement C5 as a druggable protein in periodontitis.
Frontiers in immunology - 1 Jan 2024
Alayash Zoheir, Baumeister Sebastian-Edgar, Holtfreter Birte, Kocher Thomas, Baurecht Hansjörg, Ehmke Benjamin, Reckelkamm Stefan Lars, Nolde Michael
Abstract excerpt
Aim: An excessively activated or dysregulated complement system has been proven to be a vital contributor to the pathogenesis of periodontitis. It has been previously hypothesized that inhibiting the activity of complement component C5 by targeting the C5a receptor is a powerful candidate for treating periodontitis. Here, we apply the drug target instrumental variable (IV) approach to investigate the therapeutic...
Topics
Join the communities discussing this publication.
